SHOT VS CVM Stock Comparison

Performance

SHOT
100/100

SHOT returned 91.94% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.

CVM
10/100

CVM returned -64.83% in the last 12 months. Based on SPY's performance of -20.72%, its performance is below average giving it a score of 10 of 100.

Profit

SHOT
10/100

Out of the last 18 quarters, SHOT has had 0 profitable quarters and has increased their profits year over year on 0 of them.

CVM
10/100

Out of the last 20 quarters, CVM has had 1 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

SHOT
67/100

SHOT has had a higher than average amount of volatility over the last 12 months giving it a score of 66 of 100.

CVM
70/100

CVM has had a higher than average amount of volatility over the last 12 months giving it a score of 70 of 100.

Analyst Price Targets

SHOT

"Analyst Price Targets" not found for SHOT

CVM
50/100

1 analysts offer 12-month price targets for CVM. Together, they have an average target of 0, the most optimistic target put CVM at 0 within 12-months and the most pessimistic has CVM at 0.

Sentiment

SHOT

"Sentiment" not found for SHOT

CVM
69/100

CVM had a bullish sentiment score of 69.42% across Twitter and StockTwits over the last 12 months. It had an average of 18.88 posts, 118.68 comments, and 270.58 likes per day.

Technicals

SHOT

"Technicals" not found for SHOT

CVM
10/100

CVM receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Earnings

SHOT

"Earnings" not found for SHOT

CVM
10/100

CVM has missed earnings 13 times in the last 20 quarters.

All score calculations are broken down here to help you make more informed investing decisions

Safety Shot, Inc. Common Stock Summary

Nasdaq / SHOT

Healthcare

Drug Manufacturers - Specialty & Generic

Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Cel-Sci Corporation Summary

Healthcare

Biotechnology

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Power up your portfolio